Literature DB >> 11997177

Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct.

M Ivelisse González1, Alessandra Tovaglieri, Diane M Robins.   

Abstract

POU domain proteins interact positively or negatively with steroid hormone receptors, depending on the precise array of these and other factors assembled on target gene promoters. Octamer transcription factor 1 (Oct-1), a ubiquitous POU factor, is implicated in androgen induction of the mouse sex-limited protein (Slp) gene based on protein-DNA interaction studies. However, direct evidence for a role of Oct-1 in the hormone response has been difficult to obtain. Brain 1 (Brn-1), another POU factor, is more tissue-specific, expressing in brain and also in kidney, which is a major site of Slp synthesis. We compared the interaction of the androgen receptor (AR) with Oct-1 and Brn-1 to reveal the more likely candidate for regulation of Slp. In transfection, addition of either Oct-1 or Brn-1 reduced AR activation, regardless of the presence of an octamer-like sequence in the enhancer, suggesting interference was indirect. However, when the octamer-like element was changed to a consensus octamer site, Brn-1, but not Oct-1, strongly enhanced androgen activation. This correlated with Brn-l's preference for the consensus octamer sequence in DNA binding assays. Direct interaction of AR with glutathione-S-transferase-(GST)-fused Oct-1 was DNA-dependent, while Brn-l-AR association was not. Chimeric Brn-1 and Oct-1 POU domains demonstrated that the DNA-dependent AR interaction relied on the origin of the POU homeodomain. However, in the context of full-length Brn-1 and Oct-1 chimeric proteins, the POU homedomain was not sufficient to confer the distinct behaviors of these factors in vivo, but instead revealed the importance of an N-terminal transactivation domain in Brn-1. These results demonstrate that functional interaction of Oct-1 and Brn-1 with AR is determined by the precise sequence of the octamer binding site, and by differential interaction of the POU factors with AR and other components of the transcriptional machinery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997177     DOI: 10.1016/s0303-7207(02)00035-7

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Androgen receptor repression of GnRH gene transcription.

Authors:  Melissa J Brayman; Patricia A Pepa; Sara E Berdy; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression.

Authors:  JianFeng Zhang; Nan Gao; David J DeGraff; Xiuping Yu; Qian Sun; Thomas C Case; Susan Kasper; Robert J Matusik
Journal:  Prostate       Date:  2010-06-15       Impact factor: 4.104

Review 3.  Androgen receptor signaling and mutations in prostate cancer.

Authors:  Shahriar Koochekpour
Journal:  Asian J Androl       Date:  2010-08-16       Impact factor: 3.285

4.  Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions.

Authors:  Unnati Jariwala; Jon P Cogan; Li Jia; Baruch Frenkel; Gerhard A Coetzee
Journal:  Prostate       Date:  2009-03-01       Impact factor: 4.104

5.  Discovering modulators of gene expression.

Authors:  Ozgün Babur; Emek Demir; Mithat Gönen; Chris Sander; Ugur Dogrusoz
Journal:  Nucleic Acids Res       Date:  2010-05-13       Impact factor: 16.971

6.  Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity.

Authors:  Li Jia; Benjamin P Berman; Unnati Jariwala; Xiting Yan; Jon P Cogan; Allison Walters; Ting Chen; Grant Buchanan; Baruch Frenkel; Gerhard A Coetzee
Journal:  PLoS One       Date:  2008-11-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.